| GLUE Shares Outstanding History Table | ||||||||||||||||||||||||||||||||||||||||||
Below is a table of the GLUE shares outstanding history going back to 6/24/2021:
Also see: GLUE Market Cap History GLUE YTD Return |
GLUE Shares Outstanding History — Monte Rosa Therapeutics Share Count Over Time
As of 5/1/2026 Monte Rosa Therapeutics has 84.48 million GLUE shares outstanding. Investors often track the GLUE shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows GLUE share count trends over time, with 20 historical shares outstanding datapoints presented, dating back to 6/24/2021.
| GLUE Shares Outstanding History Chart | |||||||||||||||||||||||||||||||||||||||||||
GLUE Historical Shares Outstanding: +15.18% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||
| GLUE Stock Price Chart |
| About Monte Rosa Therapeutics Inc |
| Monte Rosa Therapeutics, Inc. is a clinical-stage biotechnology company. Co. is engaged in developing a portfolio of novel and molecular glue degraders (MGDs) for patients living with serious diseases in the areas of oncology and autoimmune, and more. MGDs are small molecule drugs that employ the body's natural protein destruction mechanisms to selectively degrade therapeutically relevant proteins. It has developed a degradation platform, called Quantitative and Engineered Elimination of Neosubstrates (QuEEN) to enable its target centric MGD discovery and development approach and its rational design of MGD product candidates. We show 20 historical shares outstanding datapoints in our coverage of GLUE's shares outstanding history. Understanding the changing numbers of GLUE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like GLUE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching GLUE by allowing them to research GLUE shares outstanding history as well as any other stock in our coverage universe. |
| GLUE Current Stock Quote |
Quotes delayed 20 minutes  Free GLUE Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: Shares Outstanding Importance | |
|
Video: Shares Outstanding Importance
| GLUE Share Performance |
| Shares Outstanding Peers |
| Monte Rosa Therapeutics (GLUE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
GLXY Shares Outstanding History GLYC Shares Outstanding History GMED Shares Outstanding History GMTX Shares Outstanding History GNCA Shares Outstanding History GNLX Shares Outstanding History GNMK Shares Outstanding History GNMX Shares Outstanding History GNPX Shares Outstanding History GOSS Shares Outstanding History More Healthcare companies » |
GLUE Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
